Calavo Growers (CVGW) Financials

$26.64 -0.45 (-1.65%)

Closing price 05/6/2025 03:59 PM Eastern

Extended Trading

$27.37 +0.73 (+2.74%)

As of 04:16 AM Eastern

Annual Income Statements for Calavo Growers

This table shows Calavo Growers' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2022	2023	2024
Period end date	10/31/2022	10/31/2023	10/31/2024
Net Income / (Loss) Attributable to Common Shareholders	-6.25	-8.34	-1.08
Consolidated Net Income / (Loss)	-6.60	-7.97	-1.02
Net Income / (Loss) Continuing Operations	-6.85	5.05	6.85
Total Pre-Tax Income	-3.12	12	9.65
Total Operating Income	6.79	12	17
Total Gross Profit	55	63	68
Total Revenue	770	594	662
Operating Revenue	770	594	662
Total Cost of Revenue	715	531	594
Operating Cost of Revenue	715	531	594
Total Operating Expenses	48	50	51
Selling, General & Admin Expense	47	47	50
Other Special Charges / (Income)	1.42	3.13	1.04
Total Other Income / (Expense), net	-9.91	-0.13	-7.07
Interest Expense	1.63	2.37	2.89
Interest & Investment Income	0.50	0.61	1.02
Other Income / (Expense), net	-8.78	1.64	-5.20
Income Tax Expense	3.17	6.15	2.33
Other Gains / (Losses), net	-0.56	-0.88	-0.48
Net Income / (Loss) Discontinued Operations	0.25	-13	-7.87
Net Income / (Loss) Attributable to Noncontrolling Interest	-0.35	0.38	0.05
Basic Earnings per Share	($0.35)	($0.47)	($0.06)
Weighted Average Basic Shares Outstanding	17.66M	17.75M	17.80M
Diluted Earnings per Share	($0.35)	($0.47)	($0.06)
Weighted Average Diluted Shares Outstanding	17.75M	17.85M	17.86M
Weighted Average Basic & Diluted Shares Outstanding	17.73M	17.80M	17.84M

This table shows Calavo Growers' income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025
Period end date	7/31/2022	10/31/2022	1/31/2023	4/30/2023	7/31/2023	10/31/2023	1/31/2024	4/30/2024	7/31/2024	10/31/2024	1/31/2025
Net Income / (Loss) Attributable to Common Shareholders	1.30	-3.32	-3.07	-4.00	6.63	-7.91	-6.27	6.06	-0.73	-0.14	4.42
Consolidated Net Income / (Loss)	1.32	-3.48	-2.80	-3.96	6.71	-7.92	-6.26	6.10	-0.76	-0.10	4.44
Net Income / (Loss) Continuing Operations	1.32	-3.73	-0.45	1.45	8.74	-4.69	-2.57	6.51	5.37	-2.45	4.44
Total Pre-Tax Income	2.57	-0.45	-0.64	1.99	12	-0.91	-2.00	6.69	4.50	0.46	4.83
Total Operating Income	1.55	3.82	-0.61	1.92	10	0.68	-3.09	7.14	9.36	1.61	5.05
Total Gross Profit	19	1.26	13	16	22	12	11	20	20	15	16
Total Revenue	342	-178	133	158	161	142	128	184	180	170	154
Operating Revenue	342	-178	133	158	161	142	128	184	180	170	154
Total Cost of Revenue	323	-179	120	143	139	130	117	164	160	155	139
Operating Cost of Revenue	323	-179	120	143	139	130	117	164	160	155	139
Total Operating Expenses	17	-2.56	14	14	12	11	14	13	11	13	11
Selling, General & Admin Expense	17	-1.96	12	13	13	9.28	13	13	11	13	10
Other Special Charges / (Income)	0.30	0.27	2.05	0.39	-1.20	1.90	0.38	0.20	-	-	0.40
Total Other Income / (Expense), net	1.02	-4.26	-0.04	0.06	1.43	-1.58	1.08	-0.44	-4.86	-1.15	-0.22
Interest Expense	0.49	0.36	0.38	0.24	0.77	0.98	0.82	0.96	0.83	0.27	0.21
Interest & Investment Income	-	-	-	-	-	-	0.00	-	-	-	0.85
Other Income / (Expense), net	1.50	-4.41	0.34	0.31	2.20	-1.21	1.91	0.52	-4.02	-1.90	-0.85
Income Tax Expense	0.98	3.53	-0.04	0.48	2.41	3.30	0.57	0.39	-1.44	2.80	1.26
Other Gains / (Losses), net	-0.27	0.25	0.16	-0.06	-0.50	-0.48	0.00	0.20	-0.58	-0.10	0.86
Net Income / (Loss) Discontinued Operations	-	-	-2.35	-5.41	-2.03	-3.23	-3.68	-0.41	-6.13	2.35	0.00
Net Income / (Loss) Attributable to Noncontrolling Interest	0.02	-0.17	0.27	0.04	0.08	-0.01	0.01	0.04	-0.03	0.04	0.02
Basic Earnings per Share	$0.07	($0.18)	($0.17)	($0.23)	$0.37	($0.44)	($0.35)	$0.34	($0.04)	($0.01)	$0.25
Weighted Average Basic Shares Outstanding	17.67M	17.66M	17.67M	17.72M	17.76M	17.75M	17.80M	17.80M	17.80M	17.80M	17.84M
Diluted Earnings per Share	$0.07	($0.18)	($0.17)	($0.23)	$0.37	($0.44)	($0.35)	$0.34	($0.04)	($0.01)	$0.25
Weighted Average Diluted Shares Outstanding	17.77M	17.75M	17.67M	17.88M	17.86M	17.85M	17.80M	17.87M	17.84M	17.86M	17.90M
Weighted Average Basic & Diluted Shares Outstanding	17.73M	17.73M	17.74M	17.78M	17.76M	17.80M	17.80M	17.80M	17.80M	17.84M	17.84M
Cash Dividends to Common per Share	-	-	$0.29	$0.10	$0.10	-	$0.10	$0.10	$0.10	-	$0.10

This table details how cash moves in and out of Calavo Growers' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2022	2023	2024
Period end date	10/31/2022	10/31/2023	10/31/2024
Net Change in Cash & Equivalents	0.28	-0.28	54
Net Cash From Operating Activities	50	-14	24
Net Cash From Continuing Operating Activities	50	-14	24
Net Income / (Loss) Continuing Operations	-6.60	-7.97	-1.02
Consolidated Net Income / (Loss)	-6.60	-7.97	-1.02
Depreciation Expense	17	17	11
Amortization Expense	0.00	0.00	0.29
Non-Cash Adjustments To Reconcile Net Income	5.13	2.29	14
Changes in Operating Assets and Liabilities, net	35	-26	0.27
Net Cash From Investing Activities	8.68	-11	80
Net Cash From Continuing Investing Activities	8.68	-11	80
Purchase of Property, Plant & Equipment	-9.77	-11	-2.89
Divestitures	0.00	0.00	83
Sale and/or Maturity of Investments	18	0.00	0.00
Net Cash From Financing Activities	-59	25	-50
Net Cash From Continuing Financing Activities	-59	25	-50
Repayment of Debt	-306	-226	-126
Payment of Dividends	-20	-10	-8.92
Issuance of Debt	267	261	85
Other Financing Activities, net	0.19	0.05	-0.67
Cash Interest Paid	1.48	2.49	2.64
Cash Income Taxes Paid	2.60	1.49	2.29

This table details how cash moves in and out of Calavo Growers' business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025
Period end date	7/31/2022	10/31/2022	1/31/2023	4/30/2023	7/31/2023	10/31/2023	1/31/2024	4/30/2024	7/31/2024	10/31/2024	1/31/2025
Net Change in Cash & Equivalents	0.20	-0.33	-1.34	2.40	-2.04	0.69	2.81	-1.39	-3.15	56	-8.54
Net Cash From Operating Activities	21	8.05	-5.88	2.10	-15	4.73	0.06	2.09	11	11	-4.43
Net Cash From Continuing Operating Activities	21	8.05	-5.88	2.10	-15	4.73	0.06	2.09	11	11	-4.43
Net Income / (Loss) Continuing Operations	1.32	-3.48	-2.80	-3.96	6.71	-7.92	-6.26	6.10	-0.76	-0.10	4.44
Consolidated Net Income / (Loss)	1.32	-3.48	-2.80	-3.96	6.71	-7.92	-6.26	6.10	-0.76	-0.10	4.44
Depreciation Expense	4.07	4.12	4.17	4.29	4.36	4.47	4.56	2.08	2.04	1.93	1.94
Non-Cash Adjustments To Reconcile Net Income	-20	-12	1.07	11	-5.25	-4.47	9.63	18	-3.57	-9.57	0.64
Changes in Operating Assets and Liabilities, net	36	19	-8.32	-9.16	-21	13	-7.87	-24	14	18	-11
Net Cash From Investing Activities	-3.95	16	-5.19	-3.28	-1.63	-0.60	-1.03	-1.35	-0.14	83	-0.28
Net Cash From Continuing Investing Activities	-3.95	16	-5.19	-3.28	-1.63	-0.60	-1.03	-1.35	-0.14	83	-0.28
Purchase of Property, Plant & Equipment	-3.95	-2.03	-5.19	-3.28	-1.63	-0.60	-1.03	-1.35	-0.14	-0.37	-0.28
Net Cash From Financing Activities	-17	-25	9.72	3.58	15	-3.44	3.78	-2.13	-14	-38	-3.83
Net Cash From Continuing Financing Activities	-17	-25	9.72	3.58	15	-3.44	3.78	-2.13	-14	-38	-3.83
Repayment of Debt	-69	-71	-50	-61	-72	-43	-23	-54	-25	-23	-0.33
Payment of Dividends	-	-	-5.10	-1.77	-1.78	-1.78	-1.78	-1.78	-1.78	-3.58	-3.57
Issuance of Debt	53	46	65	66	88	42	29	54	13	-10	0.11
Other Financing Activities, net	-	0.24	0.05	-	-	-	-0.60	-0.03	-	-0.04	-0.05

This table presents Calavo Growers' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2022	2023	2024
Period end date	10/31/2022	10/31/2023	10/31/2024
Total Assets	386	387	301
Total Current Assets	126	133	159
Cash & Equivalents	2.06	2.09	57
Accounts Receivable	59	34	42
Inventories, net	51	46	49
Prepaid Expenses	8.87	12	9.98
Current Deferred & Refundable Income Taxes	3.40	1.09	0.94
Plant, Property, & Equipment, net	0.00	61	54
Total Noncurrent Assets	260	193	88
Long-Term Investments	3.78	2.90	2.42
Goodwill	29	10	10
Noncurrent Deferred & Refundable Income Taxes	5.43	3.01	7.47
Other Noncurrent Operating Assets	215	71	68
Total Liabilities & Shareholders' Equity	386	387	301
Total Liabilities	162	177	99
Total Current Liabilities	102	82	73
Accounts Payable	10	5.10	8.74
Accrued Expenses	52	16	28
Current Deferred & Payable Income Tax Liabilities	-	0.00	2.77
Other Current Liabilities	40	30	34
Total Noncurrent Liabilities	60	95	26
Other Noncurrent Operating Liabilities	59	26	26
Commitments & Contingencies	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	223	210	202
Total Preferred & Common Equity	222	209	200
Total Common Equity	222	209	200
Common Stock	171	176	178
Retained Earnings	51	32	22
Noncontrolling Interest	1.02	1.39	1.44

This table presents Calavo Growers' assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q1 2023	Q2 2023	Q3 2023	Q1 2024	Q2 2024	Q3 2024	Q1 2025
Period end date	7/31/2022	1/31/2023	4/30/2023	7/31/2023	1/31/2024	4/30/2024	7/31/2024	1/31/2025
Total Assets	431	396	407	415	395	411	382	299
Total Current Assets	148	133	145	150	246	262	238	158
Cash & Equivalents	2.51	1.80	4.20	1.40	5.66	4.27	1.13	48
Accounts Receivable	78	62	69	76	35	56	52	47
Inventories, net	49	54	56	55	53	53	45	50
Prepaid Expenses	9.22	11	11	13	10	8.19	8.86	12
Current Deferred & Refundable Income Taxes	8.50	4.12	4.33	4.15	0.89	2.06	3.61	0.94
Plant, Property, & Equipment, net	114	116	0.00	114	59	58	56	53
Total Noncurrent Assets	168	148	262	150	90	91	88	88
Long-Term Investments	25	3.94	3.88	3.38	2.90	3.11	2.53	3.29
Goodwill	29	29	29	29	10	10	10	10
Noncurrent Deferred & Refundable Income Taxes	5.32	5.43	5.59	5.78	3.01	3.01	3.01	7.47
Other Noncurrent Operating Assets	101	103	218	106	73	75	72	67
Total Liabilities & Shareholders' Equity	431	396	407	415	395	411	382	299
Total Liabilities	205	180	194	196	192	204	177	96
Total Current Liabilities	118	105	116	101	121	133	117	71
Accounts Payable	12	17	19	16	4.92	6.51	9.82	6.73
Accrued Expenses	52	52	50	42	21	20	17	30
Current Deferred & Payable Income Tax Liabilities	-	-	-	-	-	-	-	4.12
Other Current Liabilities	54	34	45	42	37	53	42	30
Total Noncurrent Liabilities	86	75	78	95	71	71	61	25
Other Noncurrent Operating Liabilities	56	53	51	55	26	25	27	25
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	226	217	213	219	203	207	205	203
Total Preferred & Common Equity	225	215	212	218	201	206	204	201
Total Common Equity	225	215	212	218	201	206	204	201
Common Stock	170	173	175	176	177	177	178	178
Retained Earnings	54	43	37	42	24	29	26	23
Noncontrolling Interest	1.18	1.29	1.32	1.41	1.40	1.44	1.41	1.46

This table displays calculated financial ratios and metrics derived from Calavo Growers' official financial filings.

Metric	2022	2023	2024
Period end date	10/31/2022	10/31/2023	10/31/2024
Growth Metrics	-	-	-
Revenue Growth	-27.10%	-22.81%	11.35%
EBITDA Growth	-21.41%	113.19%	-28.00%
EBIT Growth	-297.42%	796.48%	-16.77%
NOPAT Growth	-97.47%	26.18%	111.75%
Net Income Growth	44.62%	-20.68%	87.15%
EPS Growth	47.76%	-34.29%	87.23%
Operating Cash Flow Growth	270.12%	-128.80%	268.80%
Free Cash Flow Firm Growth	-77.59%	42.20%	-52.72%
Invested Capital Growth	-15.57%	-26.58%	-10.94%
Revenue Q/Q Growth	-36.96%	-14.58%	-34.61%
EBITDA Q/Q Growth	485.25%	0.08%	97.92%
EBIT Q/Q Growth	90.49%	-2.30%	733.88%
NOPAT Q/Q Growth	148.80%	-17.20%	352.12%
Net Income Q/Q Growth	59.14%	-125.69%	88.42%
EPS Q/Q Growth	61.11%	-123.81%	87.76%
Operating Cash Flow Q/Q Growth	15.85%	-29.75%	33.33%
Free Cash Flow Firm Q/Q Growth	59.77%	463.65%	-70.55%
Invested Capital Q/Q Growth	-4.95%	-37.03%	-7.64%
Profitability Metrics	-	-	-
Gross Margin	7.11%	10.54%	10.25%
EBITDA Margin	1.90%	5.24%	3.39%
Operating Margin	0.88%	2.05%	2.53%
EBIT Margin	-0.26%	2.33%	1.74%
Profit (Net Income) Margin	-0.86%	-1.34%	-0.15%
Tax Burden Percent	211.67%	-65.95%	-10.61%
Interest Burden Percent	156.89%	87.25%	83.75%
Effective Tax Rate	0.00%	50.89%	24.09%
Return on Invested Capital (ROIC)	2.00%	3.18%	8.40%
ROIC Less NNEP Spread (ROIC-NNEP)	-88.11%	52.92%	33.37%
Return on Net Nonoperating Assets (RNNOA)	-4.93%	-6.85%	-8.90%
Return on Equity (ROE)	-2.93%	-3.67%	-0.50%
Cash Return on Invested Capital (CROIC)	18.88%	33.83%	19.98%
Operating Return on Assets (OROA)	-0.48%	3.58%	3.35%
Return on Assets (ROA)	-1.59%	-2.06%	-0.30%
Return on Common Equity (ROCE)	-2.92%	-3.65%	-0.49%
Return on Equity Simple (ROE_SIMPLE)	-2.97%	-3.81%	-0.51%
Net Operating Profit after Tax (NOPAT)	4.75	5.99	13
NOPAT Margin	0.62%	1.01%	1.92%
Net Nonoperating Expense Percent (NNEP)	90.11%	-49.74%	-24.97%
Return On Investment Capital (ROIC_SIMPLE)	2.12%	2.40%	6.29%
Cost of Revenue to Revenue	92.89%	89.46%	89.75%
SG&A Expenses to Revenue	6.05%	7.96%	7.56%
R&D to Revenue	0.00%	0.00%	0.00%
Operating Expenses to Revenue	6.23%	8.48%	7.72%
Earnings before Interest and Taxes (EBIT)	-1.99	14	12
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	15	31	22
Valuation Ratios	-	-	-
Price to Book Value (P/BV)	2.63	2.10	2.34
Price to Tangible Book Value (P/TBV)	3.14	2.21	2.47
Price to Revenue (P/Rev)	0.76	0.74	0.71
Price to Earnings (P/E)	0.00	0.00	0.00
Dividend Yield	3.48%	2.38%	1.90%
Earnings Yield	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	2.67	2.96	2.89
Enterprise Value to Revenue (EV/Rev)	0.75	0.80	0.62
Enterprise Value to EBITDA (EV/EBITDA)	39.78	15.19	18.35
Enterprise Value to EBIT (EV/EBIT)	0.00	34.14	35.68
Enterprise Value to NOPAT (EV/NOPAT)	122.27	78.85	32.39
Enterprise Value to Operating Cash Flow (EV/OCF)	11.56	0.00	16.84
Enterprise Value to Free Cash Flow (EV/FCFF)	12.94	7.40	13.62
Leverage & Solvency	-	-	-
Debt to Equity	0.01	0.19	0.00
Long-Term Debt to Equity	0.01	0.18	0.00
Financial Leverage	0.06	-0.13	-0.27
Leverage Ratio	1.85	1.78	1.67
Compound Leverage Factor	2.90	1.55	1.40
Debt to Total Capital	0.53%	15.68%	0.00%
Short-Term Debt to Total Capital	0.00%	0.26%	0.00%
Long-Term Debt to Total Capital	0.53%	15.42%	0.00%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.45%	0.56%	0.72%
Common Equity to Total Capital	99.01%	83.76%	99.28%
Debt to EBITDA	0.08	1.26	0.00
Net Debt to EBITDA	-0.39	1.07	0.00
Long-Term Debt to EBITDA	0.08	1.23	0.00
Debt to NOPAT	0.25	6.52	0.00
Net Debt to NOPAT	-1.20	5.56	0.00
Long-Term Debt to NOPAT	0.25	6.41	0.00
Altman Z-Score	4.40	3.42	5.60
Noncontrolling Interest Sharing Ratio	0.53%	0.56%	0.69%
Liquidity Ratios	-	-	-
Current Ratio	1.23	1.63	2.17
Quick Ratio	0.60	0.44	1.35
Cash Flow Metrics	-	-	-
Free Cash Flow to Firm (FCFF)	45	64	30
Operating Cash Flow to CapEx	514.21%	-135.27%	844.95%
Free Cash Flow to Firm to Interest Expense	27.52	26.92	10.43
Operating Cash Flow to Interest Expense	30.80	-6.10	8.44
Operating Cash Flow Less CapEx to Interest Expense	24.81	-10.61	7.44
Efficiency Ratios	-	-	-
Asset Turnover	1.85	1.54	1.92
Accounts Receivable Turnover	11.16	12.79	17.45
Inventory Turnover	14.49	10.90	12.50
Fixed Asset Turnover	0.00	0.00	11.49
Accounts Payable Turnover	70.68	68.43	85.81
Days Sales Outstanding (DSO)	32.69	28.54	20.91
Days Inventory Outstanding (DIO)	25.20	33.48	29.20
Days Payable Outstanding (DPO)	5.16	5.33	4.25
Cash Conversion Cycle (CCC)	52.73	56.69	45.85
Capital & Investment Metrics	-	-	-
Invested Capital	218	160	142
Invested Capital Turnover	3.24	3.15	4.38
Increase / (Decrease) in Invested Capital	-40	-58	-17
Enterprise Value (EV)	581	473	411
Market Capitalization	586	438	469
Book Value per Share	$12.54	$11.76	$11.25
Tangible Book Value per Share	$10.52	$11.17	$10.68
Total Capital	225	249	202
Total Debt	1.20	39	0.00
Total Long-Term Debt	1.20	38	0.00
Net Debt	-5.72	33	-59
Capital Expenditures (CapEx)	9.77	11	2.89
Debt-free, Cash-free Net Working Capital (DFCFNWC)	21	49	28
Debt-free Net Working Capital (DFNWC)	24	52	85
Net Working Capital (NWC)	24	52	85
Net Nonoperating Expense (NNE)	11	14	14
Net Nonoperating Obligations (NNO)	-5.72	-50	-59
Total Depreciation and Amortization (D&A)	17	17	11
Debt-free, Cash-free Net Working Capital to Revenue	2.67%	8.32%	4.28%
Debt-free Net Working Capital to Revenue	3.08%	8.80%	12.91%
Net Working Capital to Revenue	3.08%	8.69%	12.91%
Earnings Adjustments	-	-	-
Adjusted Basic Earnings per Share	($0.35)	($0.47)	($0.06)
Adjusted Weighted Average Basic Shares Outstanding	17.66M	17.75M	17.80M
Adjusted Diluted Earnings per Share	($0.35)	($0.47)	($0.06)
Adjusted Weighted Average Diluted Shares Outstanding	17.66M	17.75M	17.86M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	17.73M	17.80M	17.84M
Normalized Net Operating Profit after Tax (NOPAT)	5.74	11	13
Normalized NOPAT Margin	0.75%	1.81%	2.04%
Pre Tax Income Margin	-0.41%	2.03%	1.46%
Debt Service Ratios	-	-	-
EBIT to Interest Expense	-1.22	5.84	3.98
NOPAT to Interest Expense	2.91	2.53	4.39
EBIT Less CapEx to Interest Expense	-7.21	1.33	2.98
NOPAT Less CapEx to Interest Expense	-3.08	-1.98	3.39
Payout Ratios	-	-	-
Dividend Payout Ratio	-307.94%	-130.95%	-871.19%
Augmented Payout Ratio	-307.94%	-130.95%	-871.19%

This table displays calculated financial ratios and metrics derived from Calavo Growers' official financial filings.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025
Period end date	7/31/2022	10/31/2022	1/31/2023	4/30/2023	7/31/2023	10/31/2023	1/31/2024	4/30/2024	7/31/2024	10/31/2024	1/31/2025
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	19.99%	-165.03%	-51.56%	-52.24%	-52.96%	179.98%	-3.88%	16.49%	11.65%	19.52%	20.99%
EBITDA Growth	52.37%	123.73%	2,771.92%	59.05%	135.48%	11.65%	-13.43%	49.32%	-56.01%	-58.38%	81.76%
EBIT Growth	2,445.83%	96.98%	94.06%	44,520.00%	306.19%	10.34%	-344.53%	243.12%	-57.00%	45.37%	456.20%
NOPAT Growth	123.56%	122.60%	79.75%	-52.82%	745.79%	-82.28%	-410.08%	361.69%	52.49%	-1,844.43%	272.87%
Net Income Growth	110.20%	73.29%	32.81%	-1,334.78%	409.34%	-127.39%	-123.86%	254.02%	-111.36%	98.69%	170.88%
EPS Growth	109.46%	75.34%	26.09%	-2,200.00%	428.57%	-144.44%	-105.88%	247.83%	-110.81%	97.73%	171.43%
Operating Cash Flow Growth	956.87%	584.44%	-346.06%	-88.93%	-173.95%	-41.21%	100.99%	-0.29%	174.14%	128.99%	-7,732.76%
Free Cash Flow Firm Growth	2,585.70%	4,078.05%	224.56%	-68.05%	-143.04%	36.22%	244.69%	550.19%	771.09%	-84.16%	-88.32%
Invested Capital Growth	-14.18%	-15.57%	-8.73%	-4.46%	10.83%	-26.58%	-33.28%	-31.52%	-39.28%	-10.94%	-3.27%
Revenue Q/Q Growth	3.19%	-151.99%	-45.49%	19.22%	1.63%	-11.60%	-10.27%	44.49%	-2.60%	-5.37%	-9.16%
EBITDA Q/Q Growth	73.79%	-50.48%	-0.33%	67.09%	157.30%	-76.52%	-14.25%	188.21%	-24.20%	-77.79%	274.50%
EBIT Q/Q Growth	61,000.00%	-119.31%	-30.54%	941.89%	456.21%	-104.26%	-122.68%	749.83%	-30.29%	-105.42%	1,551.90%
NOPAT Q/Q Growth	-68.95%	178.82%	-120.07%	443.65%	456.62%	-94.16%	-556.51%	796.58%	83.84%	-166.82%	145.24%
Net Income Q/Q Growth	577.17%	-364.46%	19.75%	-41.68%	269.39%	-218.07%	21.00%	197.47%	-112.49%	86.35%	4,364.42%
EPS Q/Q Growth	800.00%	-357.14%	5.56%	-35.29%	260.87%	-218.92%	20.45%	197.14%	-111.76%	75.00%	2,600.00%
Operating Cash Flow Q/Q Growth	10.07%	-61.40%	-173.00%	135.70%	-834.99%	130.69%	-98.77%	3,506.90%	446.51%	-5.22%	-140.85%
Free Cash Flow Firm Q/Q Growth	0.18%	10.36%	-47.99%	-43.71%	-234.95%	449.33%	29.89%	4.53%	39.29%	-91.76%	-4.21%
Invested Capital Q/Q Growth	-6.44%	-4.95%	7.56%	-0.12%	8.53%	-37.03%	-2.26%	2.51%	-3.77%	-7.64%	6.16%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	5.41%	0.00%	9.86%	9.90%	13.68%	8.33%	8.43%	11.04%	11.19%	8.76%	10.19%
EBITDA Margin	2.08%	0.00%	2.94%	4.12%	10.43%	2.77%	2.65%	5.28%	4.11%	0.96%	3.98%
Operating Margin	0.45%	0.00%	-0.46%	1.22%	6.35%	0.48%	-2.42%	3.87%	5.21%	0.95%	3.27%
EBIT Margin	0.89%	0.00%	-0.20%	1.41%	7.71%	-0.37%	-0.92%	4.15%	2.97%	-0.17%	2.72%
Profit (Net Income) Margin	0.39%	0.00%	-2.11%	-2.50%	4.17%	-5.57%	-4.90%	3.31%	-0.42%	-0.06%	2.87%
Tax Burden Percent	51.25%	775.72%	435.36%	-199.30%	57.61%	872.25%	312.54%	91.13%	-16.92%	-22.76%	91.86%
Interest Burden Percent	84.12%	76.10%	242.26%	89.06%	93.83%	171.64%	169.95%	87.43%	84.39%	-158.13%	115.06%
Effective Tax Rate	38.29%	0.00%	0.00%	24.36%	20.68%	0.00%	0.00%	5.83%	-32.00%	613.35%	25.99%
Return on Invested Capital (ROIC)	1.38%	0.00%	-1.37%	3.37%	14.51%	1.05%	-5.11%	18.37%	34.12%	-21.27%	10.84%
ROIC Less NNEP Spread (ROIC-NNEP)	8.14%	0.00%	-10.74%	-22.64%	7.15%	30.95%	23.16%	23.04%	194.10%	-36.11%	9.41%
Return on Net Nonoperating Assets (RNNOA)	0.18%	0.00%	-1.23%	-2.16%	0.61%	-4.01%	-1.60%	-1.45%	-7.50%	9.63%	-2.28%
Return on Equity (ROE)	1.56%	0.00%	-2.60%	1.21%	15.12%	-2.96%	-6.71%	16.91%	26.62%	-11.64%	8.56%
Cash Return on Invested Capital (CROIC)	11.33%	18.88%	1.55%	3.76%	-7.27%	33.83%	41.76%	32.63%	50.25%	19.98%	16.55%
Operating Return on Assets (OROA)	2.45%	0.00%	-0.48%	2.82%	12.69%	-0.57%	-1.37%	10.07%	7.54%	-0.33%	5.39%
Return on Assets (ROA)	1.06%	0.00%	-5.11%	-5.01%	6.86%	-8.57%	-7.30%	8.02%	-1.08%	-0.12%	5.70%
Return on Common Equity (ROCE)	1.55%	0.00%	-2.58%	1.20%	15.03%	-2.94%	-6.67%	16.80%	26.44%	-11.56%	8.50%
Return on Equity Simple (ROE_SIMPLE)	-7.19%	0.00%	-2.43%	-4.21%	-1.62%	0.00%	-5.68%	-0.67%	-4.34%	0.00%	4.80%
Net Operating Profit after Tax (NOPAT)	0.96	2.67	-0.42	1.46	8.10	0.47	-2.16	6.72	12	-8.25	3.73
NOPAT Margin	0.28%	0.00%	-0.32%	0.92%	5.04%	0.33%	-1.69%	3.64%	6.88%	-4.86%	2.42%
Net Nonoperating Expense Percent (NNEP)	-6.76%	48.84%	9.38%	26.01%	7.36%	-29.90%	-28.27%	-4.67%	-159.98%	14.84%	1.43%
Return On Investment Capital (ROIC_SIMPLE)	-	1.19%	-	-	-	0.19%	-0.87%	-	-	-4.09%	1.84%
Cost of Revenue to Revenue	94.59%	0.00%	90.14%	90.10%	86.32%	91.67%	91.57%	88.96%	88.81%	91.24%	89.81%
SG&A Expenses to Revenue	4.87%	0.00%	8.77%	8.44%	8.08%	6.53%	10.55%	7.06%	5.85%	7.68%	6.66%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	4.96%	0.00%	10.31%	8.69%	7.33%	7.86%	10.85%	7.17%	5.98%	7.81%	6.92%
Earnings before Interest and Taxes (EBIT)	3.06	-0.59	-0.27	2.23	12	-0.53	-1.18	7.66	5.34	-0.29	4.20
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	7.12	3.53	3.90	6.52	17	3.94	3.38	9.73	7.38	1.64	6.14
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	3.09	2.63	2.58	2.63	3.03	2.10	2.25	2.32	2.08	2.34	2.03
Price to Tangible Book Value (P/TBV)	3.68	3.14	3.09	3.15	3.61	2.21	2.37	2.44	2.19	2.47	2.14
Price to Revenue (P/Rev)	0.57	0.76	0.53	0.63	0.95	0.74	0.77	0.48	0.42	0.71	0.59
Price to Earnings (P/E)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	42.50
Dividend Yield	2.94%	3.48%	0.92%	1.24%	1.31%	2.38%	1.57%	1.49%	1.68%	1.90%	3.06%
Earnings Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	2.35%
Enterprise Value to Invested Capital (EV/IC)	3.05	2.67	2.45	2.47	2.75	2.96	3.14	3.23	2.95	2.89	2.37
Enterprise Value to Revenue (EV/Rev)	0.57	0.75	0.55	0.66	1.00	0.80	0.83	0.52	0.45	0.62	0.52
Enterprise Value to EBITDA (EV/EBITDA)	0.00	39.78	30.16	26.96	22.40	15.19	16.05	24.98	40.16	18.35	14.38
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	221.50	120.07	49.16	34.14	37.98	98.47	0.00	35.68	21.19
Enterprise Value to NOPAT (EV/NOPAT)	0.00	122.27	0.00	0.00	96.23	78.85	136.76	0.00	161.97	32.39	17.62
Enterprise Value to Operating Cash Flow (EV/OCF)	16.09	11.56	13.68	23.03	0.00	0.00	0.00	0.00	24.83	16.84	17.96
Enterprise Value to Free Cash Flow (EV/FCFF)	24.83	12.94	151.16	64.36	0.00	7.40	6.03	8.05	4.44	13.62	14.08
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.14	0.01	0.11	0.13	0.18	0.19	0.23	0.22	0.16	0.00	0.00
Long-Term Debt to Equity	0.13	0.01	0.10	0.13	0.18	0.18	0.22	0.22	0.16	0.00	0.00
Financial Leverage	0.02	0.06	0.11	0.10	0.09	-0.13	-0.07	-0.06	-0.04	-0.27	-0.24
Leverage Ratio	1.83	1.85	1.97	2.00	1.90	1.78	1.89	1.95	1.88	1.67	1.71
Compound Leverage Factor	1.54	1.40	4.76	1.78	1.78	3.06	3.21	1.70	1.59	-2.64	1.97
Debt to Total Capital	12.21%	0.53%	9.62%	11.88%	15.51%	15.68%	18.40%	18.11%	14.05%	0.00%	0.00%
Short-Term Debt to Total Capital	0.59%	0.00%	0.72%	0.70%	0.16%	0.26%	0.32%	0.32%	0.34%	0.00%	0.00%
Long-Term Debt to Total Capital	11.62%	0.53%	8.90%	11.18%	15.36%	15.42%	18.09%	17.79%	13.71%	0.00%	0.00%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.46%	0.45%	0.54%	0.55%	0.54%	0.56%	0.56%	0.57%	0.59%	0.72%	0.72%
Common Equity to Total Capital	87.33%	99.01%	89.84%	87.58%	83.95%	83.76%	81.03%	81.32%	85.36%	99.28%	99.28%
Debt to EBITDA	-8.28	0.08	1.21	1.34	1.29	1.26	1.49	2.21	2.96	0.00	0.00
Net Debt to EBITDA	-0.83	-0.39	0.91	0.96	1.12	1.07	1.21	1.86	2.64	0.00	0.00
Long-Term Debt to EBITDA	-7.88	0.08	1.12	1.26	1.28	1.23	1.47	2.17	2.89	0.00	0.00
Debt to NOPAT	-3.23	0.25	-1.24	-14.92	5.56	6.52	12.72	-4.86	11.94	0.00	0.00
Net Debt to NOPAT	-0.32	-1.20	-0.93	-10.72	4.79	5.56	10.34	-4.08	10.64	0.00	0.00
Long-Term Debt to NOPAT	-3.07	0.25	-1.15	-14.04	5.50	6.41	12.50	-4.78	11.65	0.00	0.00
Altman Z-Score	5.15	4.41	4.74	4.11	4.08	3.30	3.36	4.35	4.60	5.47	5.36
Noncontrolling Interest Sharing Ratio	0.54%	0.00%	0.58%	0.57%	0.58%	0.56%	0.64%	0.66%	0.66%	0.69%	0.71%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	1.25	1.23	1.26	1.25	1.48	1.63	2.03	1.97	2.04	2.17	2.23
Quick Ratio	0.68	0.60	0.61	0.63	0.77	0.44	0.34	0.45	0.45	1.35	1.35
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	39	43	22	12	-17	58	76	80	112	9.24	8.85
Operating Cash Flow to CapEx	527.77%	396.31%	-113.33%	64.04%	-945.43%	786.05%	5.63%	155.31%	8,051.41%	2,920.75%	-1,569.86%
Free Cash Flow to Firm to Interest Expense	79.98	119.25	58.29	50.70	-21.79	59.27	91.93	83.61	134.49	33.71	41.53
Operating Cash Flow to Interest Expense	42.99	22.42	-15.59	8.60	-20.13	4.81	0.07	2.17	13.73	39.55	-20.78
Operating Cash Flow Less CapEx to Interest Expense	34.85	16.76	-29.34	-4.83	-22.26	4.20	-1.18	0.77	13.55	38.19	-22.11
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	2.74	1.85	2.43	2.00	1.65	1.54	1.49	2.43	2.54	1.92	1.98
Accounts Receivable Turnover	15.41	11.16	13.84	10.19	8.98	12.79	12.09	15.89	15.77	17.45	16.74
Inventory Turnover	22.08	14.49	16.80	13.76	12.07	10.90	9.90	16.88	18.91	12.50	11.94
Fixed Asset Turnover	0.00	0.00	9.06	0.00	6.08	0.00	6.73	0.00	11.89	11.49	12.32
Accounts Payable Turnover	105.42	70.68	66.69	42.79	44.63	68.43	47.33	71.56	71.60	85.81	105.76
Days Sales Outstanding (DSO)	23.69	32.69	26.37	35.80	40.65	28.54	30.18	22.97	23.14	20.91	21.81
Days Inventory Outstanding (DIO)	16.53	25.20	21.73	26.53	30.25	33.48	36.87	21.62	19.30	29.20	30.57
Days Payable Outstanding (DPO)	3.46	5.16	5.47	8.53	8.18	5.33	7.71	5.10	5.10	4.25	3.45
Cash Conversion Cycle (CCC)	36.76	52.73	42.63	53.81	62.72	56.69	59.34	39.49	37.34	45.85	48.92
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	229	218	234	234	254	160	156	160	154	142	151
Invested Capital Turnover	4.93	3.24	4.28	3.66	2.88	3.15	3.02	5.04	4.96	4.38	4.48
Increase / (Decrease) in Invested Capital	-38	-40	-22	-11	25	-58	-78	-74	-100	-17	-5.11
Enterprise Value (EV)	698	581	574	579	697	473	491	517	455	411	358
Market Capitalization	693	586	556	557	661	438	453	478	423	469	408
Book Value per Share	$12.66	$12.54	$12.15	$11.94	$12.24	$11.76	$11.32	$11.57	$11.45	$11.25	$11.29
Tangible Book Value per Share	$10.62	$10.52	$10.15	$9.96	$10.29	$11.17	$10.73	$10.98	$10.86	$10.68	$10.72
Total Capital	257	225	240	242	259	249	248	253	239	202	203
Total Debt	31	1.20	23	29	40	39	46	46	34	0.00	0.00
Total Long-Term Debt	30	1.20	21	27	40	38	45	45	33	0.00	0.00
Net Debt	3.15	-5.72	17	21	35	33	37	38	30	-59	-52
Capital Expenditures (CapEx)	3.95	2.03	5.19	3.28	1.63	0.60	1.03	1.35	0.14	0.37	0.28
Debt-free, Cash-free Net Working Capital (DFCFNWC)	28	21	28	26	47	49	120	126	121	28	39
Debt-free Net Working Capital (DFNWC)	32	24	30	31	49	52	125	130	123	85	87
Net Working Capital (NWC)	30	24	28	29	49	52	125	129	122	85	87
Net Nonoperating Expense (NNE)	-0.36	6.15	2.37	5.42	1.39	8.39	4.10	0.62	13	-8.15	-0.70
Net Nonoperating Obligations (NNO)	3.15	-5.72	17	21	35	-50	-46	-47	-51	-59	-52
Total Depreciation and Amortization (D&A)	4.07	4.12	4.17	4.29	4.36	4.47	4.56	2.08	2.04	1.93	1.94
Debt-free, Cash-free Net Working Capital to Revenue	2.30%	2.67%	2.64%	3.02%	6.80%	8.32%	20.35%	12.66%	12.00%	4.28%	5.65%
Debt-free Net Working Capital to Revenue	2.58%	3.08%	2.81%	3.50%	7.11%	8.80%	21.31%	13.09%	12.11%	12.91%	12.69%
Net Working Capital to Revenue	2.46%	3.08%	2.65%	3.30%	7.05%	8.69%	21.17%	13.01%	12.03%	12.91%	12.69%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.07	($0.18)	($0.17)	($0.23)	$0.37	($0.44)	($0.35)	$0.34	($0.04)	($0.01)	$0.25
Adjusted Weighted Average Basic Shares Outstanding	17.67M	17.66M	17.67M	17.72M	17.76M	17.75M	17.80M	17.80M	17.80M	17.80M	17.84M
Adjusted Diluted Earnings per Share	$0.07	($0.18)	($0.17)	($0.23)	$0.37	($0.44)	($0.35)	$0.34	($0.04)	($0.01)	$0.25
Adjusted Weighted Average Diluted Shares Outstanding	17.77M	17.75M	17.67M	17.72M	17.86M	17.85M	17.80M	17.87M	17.84M	17.86M	17.90M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	17.73M	17.73M	17.74M	17.78M	17.76M	17.80M	17.80M	17.80M	17.80M	17.84M	17.84M
Normalized Net Operating Profit after Tax (NOPAT)	1.14	2.86	1.01	1.75	7.15	1.80	-1.89	6.91	6.55	1.13	4.03
Normalized NOPAT Margin	0.33%	0.00%	0.76%	1.10%	4.44%	1.27%	-1.48%	3.75%	3.65%	0.66%	2.61%
Pre Tax Income Margin	0.75%	0.00%	-0.48%	1.26%	7.24%	-0.64%	-1.57%	3.63%	2.51%	0.27%	3.13%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	6.30	-1.64	-0.70	9.14	16.20	-0.54	-1.43	7.96	6.41	-1.05	19.70
NOPAT to Interest Expense	1.97	7.44	-1.12	5.96	10.58	0.48	-2.62	6.98	14.83	-30.13	17.53
EBIT Less CapEx to Interest Expense	-1.85	-7.30	-14.46	-4.28	14.07	-1.15	-2.68	6.56	6.24	-2.41	18.38
NOPAT Less CapEx to Interest Expense	-6.17	1.78	-14.88	-7.46	8.45	-0.13	-3.87	5.58	14.66	-31.48	16.21
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	-125.83%	-307.94%	-97.42%	-77.08%	-245.16%	-130.95%	-62.23%	-519.56%	-80.54%	-871.19%	110.75%
Augmented Payout Ratio	-125.83%	-307.94%	-97.42%	-77.08%	-245.16%	-130.95%	-62.23%	-519.56%	-80.54%	-871.19%	110.75%

Frequently Asked Questions About Calavo Growers' Financials

When does Calavo Growers's financial year end?

According to the most recent income statement we have on file, Calavo Growers' fiscal year ends in October. Their fiscal year 2024 ended on October 31, 2024.

How has Calavo Growers' net income changed over the last 2 years?

Calavo Growers' net income appears to be on a downward trend, with a most recent value of -$1.02 million in 2024, falling from -$6.60 million in 2022. The previous period was -$7.97 million in 2023. See where experts think Calavo Growers is headed by visiting Calavo Growers' forecast page.

What is Calavo Growers's operating income?

Calavo Growers's total operating income in 2024 was $16.72 million, based on the following breakdown:

Total Gross Profit: $67.80 million
Total Operating Expenses: $51.08 million

How has Calavo Growers revenue changed over the last 2 years?

Over the last 2 years, Calavo Growers' total revenue changed from $769.69 million in 2022 to $661.54 million in 2024, a change of -14.1%.

How much debt does Calavo Growers have?

Calavo Growers' total liabilities were at $99.34 million at the end of 2024, a 43.8% decrease from 2023, and a 38.8% decrease since 2022.

How much cash does Calavo Growers have?

In the past 2 years, Calavo Growers' cash and equivalents has ranged from $2.06 million in 2022 to $57.03 million in 2024, and is currently $57.03 million as of their latest financial filing in 2024.

How has Calavo Growers' book value per share changed over the last 2 years?

Over the last 2 years, Calavo Growers' book value per share changed from 12.54 in 2022 to 11.25 in 2024, a change of -10.3%.

Related Companies

This page (NASDAQ:CVGW) was last updated on 5/7/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Calavo Growers (CVGW) Financials

Frequently Asked Questions About Calavo Growers' Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Calavo Growers (CVGW) Financials

Annual Income Statements for Calavo Growers

Quarterly Income Statements for Calavo Growers

Annual Cash Flow Statements for Calavo Growers

Quarterly Cash Flow Statements for Calavo Growers

Annual Balance Sheets for Calavo Growers

Quarterly Balance Sheets for Calavo Growers

Annual Metrics and Ratios for Calavo Growers

Quarterly Metrics and Ratios for Calavo Growers

Frequently Asked Questions About Calavo Growers' Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools